1.
Ong TD, Phùng LT, Đỗ QT, Đỗ TM, Nguyễn TV. COST-EFFECTIVENESS OF SEQUENTIAL TREATMENT WITH FIRST-LINE AFATINIB VERSUS OSIMERTINIB IN NON-SMALL CELL LUNG CANCER WITH EGFR MUTATION IN VIETNAM.
VMJ
. 2023;527(2). doi:10.51298/vmj.v527i2.5854